Prof. Mohamad Mohty – FDA Breakthrough Therapy Designation for Elranatamab in Relapsed or Refractory Multiple Myeloma – International Academy for Clinical Hematology (IACH)

Register an Account

Name(Required)

First Last

Email(Required)

Country(Required)

Institution

EBAH Membership Number

Profession(Required)

Specialty

Password

Enter Password Confirm Password

CAPTCHA